This quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.
We’ve produced new guidance on gastrointestinal and liver conditions treated with drugs affecting the immune response to follow during the COVID-19 pandemic. This is relevant to statement 4 in this quality standard and may help to support using the quality standard during this time.
It does not cover treatment for liver cancer.
How to use NICE quality standards and how we develop them
Quality standards help you improve the quality of care you provide or commission. Find out how to use quality standards and how we develop them. We check our quality standards every August to make sure they are up to date.